Gene · 8638
OASL: 2'-5'-oligoadenylate synthetase like
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. OASL: 2'-5'-oligoadenylate synthetase like. Genes, record 8638. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8638
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q15646 | 2'-5'-oligoadenylate synthase-like protein | 514 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents43
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026148146 A1 | 2026-07-09 | 25 | Q15646 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 35698 | Q15646 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 145 | Q15646 | Espacenet |
| US 11884978 B2 | 2024-01-30 | 639 | Q15646 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 145 | Q15646 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 103116 | Q15646 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 7813 | Q15646 | Espacenet |
| US 10846371 B2 | 2020-11-24 | 28 | Q15646 | Espacenet |
| EP 3504344 A1 | 2019-07-03 | 828 | Q15646 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 216133 | Q15646 | Espacenet |
1 to 10 of 43
See all 43 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,371
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | OASL papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 10 | 2025 |
| P30AG017265 | USC/UCLA Center on Biodemography and Population Health | 9 | 2025 |
| U19AI135972 | SARS-CoV adaptations through a Systems Biology Lens (SYBIL) | 6 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 5 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 5 | 2025 |
| R01AR071384 | Characterization of interferon kappa as a novel target in cutaneous lupus | 5 | 2025 |
| P30AR075043 | University of Michigan Skin Biology and Diseases Resource-based Center | 4 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 4 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 4 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 4 | 2025 |
1 to 10 of 1,371Source NIH's project files
See all 1,371 nih grantsPapers1,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in Cytosolic dsRNA Sensing of Viral Infections. | Immunol Cell Biol | 2026 | 42802076 | PubTator, text mining | PubMed |
| Transcriptomic signatures of mind-body transformations therapy in breast cancer: Downregulation of the interferon signaling pathway. | Breast | 2026 | 42748847 | PubTator, text mining | PubMed |
| Tape Strip Transcriptomics Reveal Nemolizumab Effects on Pruritus, Hyperplasia, Inflammation, and Extracellular Matrix Markers in Patients With Moderate-to-Severe Atopic Dermatitis. | Allergy | 2026 | 42693785 | PubTator, text mining | PubMed |
| ACSL5 drives pancreatic ductal adenocarcinoma by suppressing mitophagy and enhancing ferroptosis resistance via the JAK1-STAT1-OASL axis. | Cancer Lett | 2026 | 42692137 | PubTator, text mining | PubMed |
| IFIT3 silencing improves the sensitivity of gliomas to temozolomide by inactivating the PI3K/AKT signaling pathway. | Behav Brain Res | 2026 | 42603632 | PubTator, text mining | PubMed |
| Transcriptomic profiling reveals selective attenuation of interferon-associated inflammatory signaling and induction of metallothioneins by a zinc-containing oral rinse. | Front Immunol | 2026 | 42577366 | PubTator, text mining | PubMed |
| Non-Cytopathic Mammalian Orthoreovirus Infection Triggers Innate Immune Responses in Human Tonsil-Derived Mesenchymal Stem Cells: Implications for Cell Therapy Quality Control. | Tissue Eng Regen Med | 2026 | 42467368 | PubTator, text mining | PubMed |
| The Effect of Arginine Supplementation on Intestinal Antioxidant Capacity, Whole Blood Cell Count and Antiviral Immune Function of Piglets Infected with Porcine Epidemic Diarrhea Virus. | Animals (Basel) | 2026 | 42450709 | PubTator, text mining | PubMed |
| Genetic and molecular architecture of multiple sclerosis in gulf cooperation council populations: A scoping review and regional precision-neurology perspective. | Mult Scler Relat Disord | 2026 | 42398277 | PubTator, text mining | PubMed |
| Alpha-herpesvirus UL55 synergizes with ICP27 to suppress type I interferon production through conserved and host-adapted mechanisms. | J Virol | 2026 | 42377976 | PubTator, text mining | PubMed |
1 to 10 of 1,763
See all 1,763 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8638
GET https://conductscience.org/api/genes/v1/8638/patents?page=2